Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2008

Nov 13, 2008

30339_dirs_2008-11-13_4e8baf14-8edd-45f0-82b0-b79366bd3317.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-11-12

Reporting Person: YOUNG ROBERT C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-11-12 Common Stock M 1000 $19.365 Acquired 12233.25 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-11-12 Stock Option (Right to Buy) $19.365 M 1000 Disposed 2015-05-05 Common Stock (1000) Direct